Assessing maladaptive sugar-rich food consumption: development and preliminary validation of the sugar misuse questionnaire
Frontiers in Nutrition · 07.08.2026 · 13
DOI: 10.3389/fnut.2026.1855019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Nutrition, online erschienen am 07.08.2026. Verfasst von Pascal Perney und 5 weiteren Autor:innen. Beteiligte Einrichtung: Addictions Department, CHU Caremeau, University of Montpellier, Montpellier, France. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Excessive consumption of sugar-rich foods is associated with adverse metabolic and health outcomes. Beyond the amount of sugar consumed, growing evidence suggests that some individuals experience maladaptive patterns of sugar-rich food consumption characterized by craving, loss of control, and persistence despite negative consequences. However, existing instruments primarily assess general food addiction or eating disorders and may not adequately capture behavioral patterns specifically related to sugar-rich products.
Method
The sugar misuse questionnaire (SuMQ) was developed using a mixed-methods approach. First, a qualitative study was conducted with individuals reporting severe difficulties related to sugar-rich food consumption to identify salient experiential dimensions of sugar misuse (SuM). Key themes were extracted through thematic analysis and used to generate questionnaire items. Second, the psychometric properties of the SuMQ were evaluated in a general population sample. Item functioning and scale structure were examined using Rasch modeling, followed by dimensionality analyses. ROC analyses were conducted to explore preliminary severity thresholds.
Results
Qualitative analyses identified 25 recurrent concepts related to maladaptive sugar-rich food consumption, which informed the initial version of the questionnaire. Rasch analysis supported a reduced 11-item version with strong internal consistency and a unidimensional structure. Exploratory threshold analyses identified score ranges associated with higher self-reported severity of SuM.
Discussion
The SuMQ provides a behaviorally grounded, preliminary psychometrically validated instrument for assessing sugar-focused maladaptive eating patterns within a dimensional framework. It may support research exploring the boundaries between addictive-like eating and established eating disorder constructs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Addictions Department, CHU Caremeau, University of Montpellier, Montpellier, France.
- INSERM U1018, Paris, France.
- University Paul Valéry Montpellier 3, University Montpellier, EPSYLON EA 4556, Montpellier, France.
- VBIC, INSERM U1047, Université de Montpellier, Service des Maladies Métaboliques et Endocriniennes, CHU Nîmes, Clinique du Pied Gard Occitanie, Le Grau du Roi, France.
- Addictions Department, Hôpital La Colombiere, University Hospital of Montpellier, Inserm U1058, Montpellier, France.
- Montpellier Faculty of Medicine, University of Montpellier, Montpellier, France.
Zitieren
APA
Perney, P., Trouillet, R., Schuldiner, S., Donnadieu, H., Lehert, P., & Naassila, M. (2026). Assessing maladaptive sugar-rich food consumption: development and preliminary validation of the sugar misuse questionnaire. Frontiers in Nutrition, 13. https://doi.org/10.3389/fnut.2026.1855019
Vancouver
Perney P, Trouillet R, Schuldiner S, Donnadieu H, Lehert P, Naassila M. Assessing maladaptive sugar-rich food consumption: development and preliminary validation of the sugar misuse questionnaire. Frontiers in Nutrition. 2026;13. doi:10.3389/fnut.2026.1855019
BibTeX
@article{Perney2026,
author = {Perney, Pascal and Trouillet, Raphaël and Schuldiner, Sophie and Donnadieu, Hélène and Lehert, Philippe and Naassila, Mickael},
title = {Assessing maladaptive sugar-rich food consumption: development and preliminary validation of the sugar misuse questionnaire},
journal = {Frontiers in Nutrition},
year = {2026},
volume = {13},
doi = {10.3389/fnut.2026.1855019}
}
EUVIMED